Asia Pacific Elderly Care Products Market Size & Share 2026-2035

Asia Pacific Elderly Care Products Market Size

Asia Pacific elderly care products market revenue reached USD 11.6 billion in 2025 and will rise to USD 22.8 billion by 2035, expanding at a 6.9% CAGR from 2026 to 2035.

The market encompasses mobility products, bathroom safety products, comfort care products, medical devices, incontinence products, nutritional supplements, and daily living aids utilized across residential homes, hospitals, clinics, nursing homes, assisted living facilities, and rehabilitation settings.

A bottom-up assessment of product-category demand across APAC countries, reconciled against end-use and channel allocations, anchors the market estimate. China, India, and Japan will contribute most of the approximately USD 9 billion in incremental revenue over 2025–2035. China will add an estimated USD 3.7 billion through volume growth and domestic premiumization. India will add about USD 1.5 billion at accessible price points, while Japan will add about USD 1.0 billion through technology-integrated premium categories. ^{[1]Population Ageing | Demographic Changes in Asia and the Pacific. population-trends-asiapacific.org}

Product growth trails the 11–13% expansion observed in related APAC home healthcare service categories because adult diapers and disposable pads remain subject to pricing pressure in China and Southeast Asia. Japan, South Korea, and Australia offset part of that pressure through smart monitoring, powered mobility, robotic rehabilitation, and therapeutic nutrition products that carry average selling prices three to ten times higher than commodity equivalents. ^{[2]UNESCAP, Ageing Societies. unescap.org}

Key Drivers

Rapid Population Aging Across All Major APAC Economies: China had 310.31 million residents aged 60 and above at end-2024, equal to 22.0% of the national population^{[3]World Health Organization South-East Asia, Ageing and Health in South-East Asia. who.int}. China’s basic old-age insurance covered more than 1.07 billion people, indicating the scale of the policy infrastructure supporting later-life consumption. Japan had 36.24 million people aged 65 and above, or 29.3% of its population. South Korea entered super-aged society status in late 2024, with 10.24 million people aged 65 and above, or 20% of the population ^{[4]World Health Organization Western Pacific, Ageing and Health WPRO. who.int}. India’s 60-plus population exceeded 156.7 million in 2024 and will reach 230 million by 2036 Australia’s 65-plus share was 16% and will reach 24% by the mid-2060s. These cohorts create enduring demand across every product category, particularly once consumers move from preventive care into mobility, continence, and chronic-condition management.

Rising Prevalence of Chronic Noncommunicable Diseases: Cardiovascular disease, diabetes, chronic respiratory disease, and musculoskeletal disorders require repeated monitoring and ongoing care support ^{[5]World Health Organization Western Pacific, Noncommunicable Diseases. who.int}. A consumer managing hypertension and diabetes can require a blood pressure monitor, glucose meter, nutritional products, and escalating mobility support during a long disease course. That connection makes medical devices and nutritional supplements less cyclical than discretionary wellness categories. Manufacturers with device connectivity can retain the consumer after the initial hardware sale through data services and repeat accessory purchases.

Expanding Healthcare Awareness and Home Care Cultural Preference: Public awareness campaigns, teleconsultation adoption, and higher health literacy have shifted household spending from post-diagnosis treatment toward preventive monitoring and nutritional support. In East and Southeast Asia, family caregiving makes aging in place more acceptable than institutional placement. Demand therefore moves into home-friendly products rather than disappearing when hospital use falls. India, Indonesia, and Vietnam will benefit most as consumer access improves through pharmacies and e-commerce. ^{[6]OECD, WHO SEARO, and WHO WPRO, "Health at a Glance: Asia/Pacific 2024". oecd.org}

Key Restraints

High Cost of Advanced Products Limiting Penetration in Price-Sensitive Markets: Powered wheelchairs, robotic exoskeletons, smart monitoring systems, hearing implants, and high-specification care beds remain inaccessible to many older consumers in South and Southeast Asia. Public reimbursement for elderly care products is partial or absent across several markets, including India, Indonesia, Vietnam, and the Philippines. The result is a two-speed market: commodity and mid-tier products gain volume, while high-value categories remain urban and affluent. Suppliers must balance localized cost structures against enough product differentiation to avoid commodity pricing.

Regulatory Complexity and Market Access Barriers Across Heterogeneous Jurisdictions: Class II and Class III devices, powered mobility aids, therapeutic supplements, and hearing instruments face distinct approval routes across China, India, Australia, and other APAC jurisdictions. China’s NMPA, India’s CDSCO, and Australia’s TGA apply different product-registration requirements. Launch timelines can extend 12–36 months for multinational entrants, particularly for technology-intensive products. The delay favors companies with local regulatory capability and established distributor networks, while smaller innovators face a higher cost of regional expansion. ^{[7]National Bureau of Statistics of China, "Population and Its Composition, 2024". stats.gov.cn}

Asia Pacific Elderly Care Products Market Segment Analysis

By Product Type

Mobility Products led the market with 13.7% of 2025 revenue, or USD 1.6 billion. The category includes manual and powered wheelchairs, walkers, rollators, mobility scooters, canes, crutches, stair lifts, and patient hoists. China provides the largest volume through hospital and nursing-home procurement, while Japan leads premium adoption of powered mobility and smart walkers. Karma Healthcare, Merits Health Products, Heartway Medical Products, Apex Medical/Wellell, Guangzhou Topmedi, and Shenzhen Zuowei Technology compete through regional manufacturing and distribution. Mobility economics split between durable, price-sensitive manual products and high-value powered or robotic systems. By 2030, product integration with rehabilitation monitoring will differentiate premium suppliers from basic equipment vendors.

Medical Devices held 20.4% of revenue, or USD 2.4 billion. Hearing aids, blood pressure monitors, cardiac monitors, glucose meters, pulse oximeters, respiratory aids, and remote patient monitoring systems comprise the category. OMRON’s OMRON Complete combined ECG and blood pressure device launched in South Korea in 2024. Cochlear’s hearing implant systems and OMRON’s connected monitoring platform show how clinical devices are becoming software-linked household products. Cardiovascular disease supports recurring monitoring demand across APAC. The key commercial transition is from stand-alone hardware toward device-plus-data services that improve clinical relevance and consumer engagement.

Incontinence Products represented 16.3% of revenue, or USD 1.9 billion, and remain the most volume-driven segment. Adult diapers, absorbent underwear, pads, liners, underpads, and external catheters serve recurring needs. Unicharm’s Lifree range and Hengan’s Chinese domestic portfolio compete in the largest markets, while Nobel Hygiene addresses Indian volume demand. Daio Paper remains an important Japanese hygiene competitor. This category depends on local manufacturing, retail coverage, product comfort, and stigma reduction more than advanced technology. Subscription delivery and skin-care-enhanced formats will support trade-up through 2035.

Nutritional Supplements held 18.9% of revenue, or USD 2.2 billion, led by bone-health, immune, metabolic, and cognitive-support products. Comfort Care Products accounted for 12%, or USD 1.5 billion, including adjustable beds, pressure-relief mattresses, heating pads, bed rails, and recliner chairs. Paramount Bed’s electrically adjustable care beds serve institutional and premium home settings.

Bathroom Safety Products represented 8.9%, or USD 1 billion, with grab bars, shower chairs, commode chairs, and toilet seat raisers addressing household fall prevention.

Daily Living Aids & Others accounted for 9.2%, or USD 1.1 billion, but will grow at a 7.4% CAGR through 2035 as adaptive utensils, dressing aids, and ergonomic tools gain online visibility.

By Care Type

Home Care & Independent Living Support is the central care-type demand pool, combining mobility aids, bathroom safety products, daily living aids, and consumer-friendly monitoring tools. Caregivers prioritize ease of installation, durable design, and products that preserve independence. Chronic Disease Management relies on blood pressure monitors, glucose monitoring, respiratory aids, therapeutic nutrition, and remote monitoring platforms. OMRON Connect Pro and AI-enabled monitoring devices create a pathway from periodic measurements to managed care. Post-Acute Rehabilitation requires mobility equipment, robotic rehabilitation systems, adjustable beds, and pressure-relief products. Cyberdyne’s HAL platform represents the premium end of this segment. Palliative & End-of-Life Care uses comfort beds, pressure-relief mattresses, hygiene products, and mobility-support equipment where caregiver burden is high. Preventive Health Management includes nutritional supplements, fall-prevention equipment, and early-detection devices. These care types overlap commercially: a household that begins with preventive monitoring may progress to chronic management and rehabilitation products as care needs intensify.

By End Use

Home-Based Care led with 43% of 2025 revenue, or USD 4.6 billion. Policy support for aging in place, family caregiving norms, and home management of chronic conditions explain its lead. The channel consumes products ranging from low-complexity pads and walkers to smart monitoring devices and adjustable beds. Hospitals & Clinics accounted for 20.5%, or USD 2.4 billion, through institutional procurement of medical devices, mobility products, and continence management supplies.

Nursing Homes & Skilled Nursing Facilities and Assisted Living & Continuing Care Retirement Communities each represented 16.8%, or USD 1.9 billion. Nursing homes prioritize durability, clinical specifications, and bulk pricing. Assisted living buyers place greater weight on appearance, resident comfort, and service integration. Adult Day Care & Rehabilitation represented 8%, or USD 0.9 billion, and will benefit as community rehabilitation programs expand in Japan, South Korea, and Australia. The second-order effect of home-care policy is not merely lower institutional demand; it shifts institutions toward higher-acuity rehabilitation and post-acute procurement.

By Distribution Channel

Offline Distribution held 75% of 2025 revenue, or USD 8.7 billion. Pharmacies, medical supply stores, specialty elderly-care retailers, and direct institutional suppliers remain central where clinical guidance, product fitting, or physical trials matter. Japan, South Korea, and Australia rely on trained advisory networks for hearing aids, monitoring devices, powered mobility products, and care beds. China’s hospital procurement portals and extensive pharmacy network reinforce offline scale.

Online Distribution held 25%, or USD 2.9 billion, and will expand at a 10.5% CAGR. Tmall, JD.com, Taobao, Flipkart, Amazon India, 1mg, Lazada, and Shopee improve access in tier-2 and tier-3 cities. Online channels are strongest for repeatable products such as incontinence supplies and nutritional supplements, where price comparison and recurring delivery matter. The channel does not replace offline care guidance for high-consideration devices; it creates a hybrid purchase path in which discovery, clinical advice, transaction, and after-sales service occur across different channels.

Asia Pacific Elderly Care Products Market Regional Analysis

China China led regional revenue with a 39.3% share, or USD 4.5 billion, in 2025 and will reach USD 9.2 billion by 2035, equal to 40.4% of the market. Its 60-plus population reached 310.31 million in 2024, including 220.23 million people aged 65 and above. The National Aging Services plan promotes community care, home-care platforms, and smart aging technology. Domestic producers such as COCO Healthcare, Shanghai Hubang Intelligent Rehab Equipment, Shanghai Bangbang Robotics/Robooter, Guangzhou Topmedi, and Shenzhen Zuowei Technology benefit from local supply chains and distribution. China’s constraint is fragmentation: no single supplier commands more than 6–7% of total elderly care product spending, which creates both price competition and acquisition opportunities.

Japan Japan represented 24.8% of 2025 revenue and will decline to 24% by 2035 as China and India grow faster. Its 29.3% share of residents aged 65 and above makes it the region’s most mature elderly care market. Japan’s long-term care insurance framework supports assistive-product adoption, while high per-capita spending supports robotic rehabilitation, connected monitoring, and smart beds. Cyberdyne’s HAL, OMRON’s ECG-integrated monitors, and Paramount Bed’s care beds demonstrate the country’s role as a premium technology proving ground. Commodity categories are near saturation, so incremental growth will come from personalized and technology-integrated care.

India India will grow at an 8.3% CAGR and increase from 10.4% of 2025 regional revenue, or USD 1.2 billion, to 11.8% by 2035. India had 156.7 million people aged 60 and above in 2024. Its growth is initially volume-led, centered on affordable incontinence products, basic mobility aids, blood pressure monitors, and supplements. Unicharm completed its third Indian manufacturing facility in Ahmedabad in February 2025, increasing domestic capacity by approximately 30%. OMRON Healthcare India targets 30% annual growth through a network of more than 600,000 pharmacies. India’s affordability constraint will slow advanced-device adoption, but local production and expanding retail reach will support a later premiumization cycle.

South Korea South Korea accounted for 7.9% of regional value and reached super-aged society status in 2025. A government demographic-policy response will address the rising elderly share, supported by Statistics Korea projections of more than 30% aged 65 and above by 2036. High internet and smartphone penetration support connected health products, premium continence care, therapeutic nutrition, and rehabilitation aids. OMRON’s COMPLETE ECG and blood pressure device illustrates the country’s readiness for multi-function consumer medical devices. Long-Term Care Insurance coverage expansion will be central to institutional purchasing growth.

Australia Australia represented 6.9% of regional market value, supported by public funding through My Aged Care and the 2025 Aged Care Act reforms. One in six Australians were aged 65 or older, and the share will reach 24% by the mid-2060s. Subsidized access to mobility aids, home modifications, and bathroom safety products provides a policy-supported demand base. Cochlear and ResMed supply high-value hearing, respiratory, and sleep-health products from Australia into wider APAC markets. Australia therefore functions as both a premium market and a regulatory-commercial reference point for suppliers entering the region.

Southeast Asia: Vietnam, Malaysia, and Indonesia Vietnam, Malaysia, Indonesia, and Thailand remain lower-penetration markets with rising urbanization, healthcare infrastructure, and middle-class demand. UNFPA identifies rapid aging as a region-wide development priority, while UN Women and UNESCAP describe the care-system and intergenerational implications of aging societies,. Thailand’s aged-society status and Cyberdyne’s August 2025 MOU with the Institute of Geriatric Medicine to advance cybernics innovation across ASEAN point to a shift from basic consumption toward government-backed medical technology partnerships. Growth will concentrate in basic mobility, incontinence, monitoring, and nutrition before premium connected products broaden their addressable base.

Asia Pacific Elderly Care Products Market Share

The Asia Pacific elderly care products market is highly fragmented. The top eight companies held approximately 52% of 2025 revenue, while the remaining 72% was distributed across regional, domestic, specialty, and niche suppliers. Fragmentation persists because product leadership changes by category, reimbursement and regulation differ by country, and local distribution channels favor domestic suppliers. ^{[8]State Council of the People’s Republic of China, "China’s Basic Old-Age Insurance Covers Over 1.07 Billion People". english.gov.cn}

Unicharm was the largest individual participant, with an estimated 6.3% of total regional market revenue. Its Lifree adult diaper and wellness care products give it particular strength in incontinence, while its Southeast Asian distribution network supports geographic expansion. The Ahmedabad facility reinforces its India strategy. OMRON leads in home blood pressure, cardiac monitoring, and remote patient monitoring, using Luscii and OMRON Connect Pro to move from hardware sales toward platform revenue. ^{[9]Statistics Bureau of Japan, "Population Estimates ". stat.go.jp}

Hengan holds scale in Chinese incontinence products. Panasonic competes in Japanese care robotics and monitoring systems. ResMed supplies respiratory and sleep-health products across Australia, Japan, and South Korea. Paramount Bed holds a leading position in Japanese adjustable care beds. Yuwell/Jiangsu Yuyue Medical supplies China’s mid-market home-monitoring demand, while Apex Medical/Wellell, Merits, Karma Healthcare, and Heartway Medical provide mobility products through Taiwan-centered manufacturing and export networks. ^{[10]The Korea Herald, South Korea Now Officially ‘Super-Aged’ Society. koreaherald.com}

Recent Industry Developments

• April 2026 — ResMed completed the USD 340 million acquisition of Noctrix Health, adding the Nidra TOMAC wearable therapy for moderate-to-severe restless legs syndrome. The transaction broadens ResMed’s sleep-health portfolio into neurological care for older adults. The wearable therapeutic fits ResMed’s connected-device and home-health channels in Japan, South Korea, and Australia. The acquisition signals a shift beyond conventional respiratory equipment toward wearable neuromodulation and subscription-linked clinical products.
• June 2026 — OMRON Healthcare acquired Life Log Technology, developer of the AI-powered Calomeal nutrition and health-management application. Calomeal combines meal logging, food-database matching, and personalized dietary guidance with connected biometric data. The acquisition allows OMRON to combine blood pressure, cardiac, and body-composition readings with lifestyle data for consumers managing cardiovascular disease and diabetes. It strengthens the case for bundled device-plus-digital services and recurring platform revenue.
• June 2025 — Cochlear launched the Nucleus Nexa System in Australia, New Zealand, Hong Kong, and China. The smart cochlear implant includes upgradeable firmware and internal memory, allowing feature upgrades without surgical device replacement. The architecture improves long-term device economics for older recipients and increases ecosystem lock-in for Cochlear. It raises the product-development threshold for competitors in premium elderly hearing care.
• March 2025 — PT Uni-Charm Indonesia launched Certainty Popok Celana, an adult incontinence pants product with breathable fabric, triple-absorption protection, and an ergonomic fit. The product targets long-duration elderly wear and seeks to reduce skin-irritation concerns. It creates a trade-up path from lower-quality local alternatives at an accessible price point. The launch supports premiumization in Indonesia’s growing incontinence market and provides a model for Vietnam, the Philippines, and Malaysia.